Connection

Abdullah Assiri to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Abdullah Assiri has written about Treatment Outcome.
Abdullah Assiri
Connection Strength
0.036
Treatment Outcome
  1. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-ß1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials. 2020 Jan 03; 21(1):8.
    View in: PubMed
    Score: 0.008
  2. Old World cutaneous leishmaniasis treatment response varies depending on parasite species, geographical location and development of secondary infection. Parasit Vectors. 2019 May 02; 12(1):195.
    View in: PubMed
    Score: 0.007
  3. Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients. Saudi J Gastroenterol. 2019 Jan-Feb; 25(1):55-60.
    View in: PubMed
    Score: 0.007
  4. Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. J Infect. 2018 06; 76(6):536-542.
    View in: PubMed
    Score: 0.007
  5. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-ß1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials. 2018 Jan 30; 19(1):81.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.